Entrada Therapeutics Inc. (TRDA)
NASDAQ: TRDA
· Real-Time Price · USD
5.29
0.04 (0.76%)
At close: Aug 15, 2025, 3:59 PM
5.27
-0.28%
After-hours: Aug 15, 2025, 04:10 PM EDT
Entrada Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.95M | 20.56M | 37.4M | 19.57M | 94.69M | 59.12M | 41.85M | 43.73M | 18.17M | 25.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 1.1M | n/a | n/a | n/a | 900K | 934K | 736K | 800K | 700K | 541K | 525K | 500K | 500K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 850K | 20.56M | 36.41M | 18.67M | 93.79M | 58.19M | 41.11M | 42.94M | 17.47M | 24.72M | -525K | -500K | -500K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -46.85M | -21.79M | -5.87M | -21.66M | 53.42M | 21.11M | 4.91M | 14.01M | -16.3M | 1.32M | -25.58M | -25.94M | -23.58M | -22.15M | -18.46M | -14.36M | -9.91M | -8.39M |
Interest Income | n/a | 4.44M | 5.13M | 5.77M | 4.37M | 4.21M | 4.29M | 4.05M | 4.22M | 2.66M | 950K | 799K | 403K | 480K | n/a | n/a | 9K | 13K |
Pretax Income | -42.92M | -17.35M | -739K | -15.89M | 57.79M | 25.33M | 9.2M | 18.06M | -12.08M | -3.12M | -24.63M | -25.14M | -23.18M | -21.67M | -18.45M | -14.43M | -9.9M | -8.38M |
Net Income | -43.1M | -17.35M | 1.13M | -14.03M | 55.03M | 23.5M | -9.54M | 35.46M | -25.93M | -6.67M | -22.2M | -23.54M | -22.37M | -20.71M | -18.43M | -14.43M | -9.9M | -8.38M |
Selling & General & Admin | 10.92M | 10.27M | 9.86M | 9.97M | 9.24M | 9.4M | 8.65M | 7.53M | 8.17M | 7.94M | 9.89M | 6.98M | 7.33M | 6.43M | 6.1M | 3.85M | 3.08M | 2.17M |
Research & Development | 37.88M | 32.07M | 32.41M | 31.26M | 31.14M | 27.67M | 27.55M | 22.19M | 26.3M | 23.1M | 15.69M | 18.96M | 16.25M | 15.72M | 12.36M | 10.51M | 6.83M | 6.22M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 48.8M | 42.35M | 42.27M | 41.23M | 40.37M | 37.07M | 36.21M | 29.72M | 34.47M | 31.04M | 25.58M | 25.94M | 23.58M | 22.15M | 18.46M | 14.36M | 9.91M | 8.39M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 950K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 42.35M | 43.27M | 41.23M | 41.27M | 38.01M | 36.94M | 29.72M | 34.47M | 31.04M | 25.58M | 25.94M | 23.58M | 22.15M | 18.46M | 14.36M | 9.91M | 8.39M |
Income Tax Expense | 178K | n/a | -1.87M | -1.86M | 2.76M | 1.83M | 18.74M | -17.4M | 13.85M | 3.55M | -2.42M | -1.6M | -806K | -960K | -13K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 41.34M | 41.07M | 40.84M | 40.63M | 34.18M | 33.5M | 33.37M | 33.28M | 33.16M | 32.37M | 31.35M | 31.3M | 31.28M | 31.25M | 20.78M | 28.31M | 20.48M | 20.48M |
Shares Outstanding (Diluted) | 41.34M | 41.07M | 43.05M | 40.63M | 35.51M | 34.79M | 33.37M | 34.78M | 33.16M | 32.37M | 31.35M | 31.3M | 31.28M | 31.25M | 20.78M | 28.31M | 20.48M | 20.48M |
EPS (Basic) | -1.04 | -0.42 | 0.03 | -0.35 | 1.61 | 0.70 | -0.29 | 1.07 | -0.78 | -0.21 | -0.71 | -0.75 | -0.72 | -0.66 | -0.89 | -0.51 | -0.48 | -0.41 |
EPS (Diluted) | -1.04 | -0.42 | 0.03 | -0.35 | 1.55 | 0.68 | -0.29 | 1.02 | -0.78 | -0.21 | -0.71 | -0.75 | -0.72 | -0.66 | -0.89 | -0.51 | -0.48 | -0.41 |
EBITDA | -46.85M | -20.84M | -4.88M | -21.66M | 53.42M | 22.05M | 5.64M | 14.01M | -15.57M | -5.24M | -25.05M | -25.42M | -23.12M | -21.76M | -18.1M | -14.06M | -9.66M | -8.19M |
EBIT | -42.92M | -21.79M | -5.87M | -21.66M | 57.79M | 25.33M | 9.2M | 18.06M | -16.3M | -5.78M | -25.58M | -25.94M | -23.58M | -22.15M | -18.46M | -14.36M | -9.91M | -8.39M |
Depreciation & Amortization | n/a | 946K | 992K | n/a | 900K | 934K | 736K | 800K | 700K | 541K | 525K | 500K | 466K | 390K | 364K | 302K | 252K | 199K |